There is disclosed a skincare composition suitable for topical application to the skin. The composition comprises salicylic acid or a salt thereof and hydrolysed milk protein. The composition is useful in the treatment of acne.

A unique composition of a 5-amino salicyclic acid (5ASA) and a phospholipid is disclosed for treating inflammatory Bowel Disease (IBD) where the composition can be a mixture a molecular association complex or a covalent compound of 5ASA and a reactive phospholipid covalently bonded together via a diazo linkage and to methods for administering the compositions to treat symptoms of IBD.

The present invention relates to coating compositions for modulating biofilm growth on a surface the composition comprising the reaction product of: A) an ethylenically unsaturated compound having at least one group with the following structure: and B) an ethylenically unsaturated compound.

The present invention relates to a compound of the formula:R-AR—O—Y—R?Wherein R represents one or more members selected from H alkoxy benzyloxy aldehyde halogen carboxylic acid —NO2 —NH2 —NHCOCH3 and —NH—Y—R? which is attached directly to AR or attached through an aliphatic chain. The carboxylic acid moiety in R includes but is not limited to the following carboxylic acids: benzoic acids cinnamic acids ferulic acid caffeic acid syringic acid salicyclic acid vanillic acid phenylacetic acids pheny...

The present invention relates to an oral pharmaceutical preparation for use in the prevention and/or reduction of gastrointestinal complications associated with the use of acetyl salicylic acid. The present preparation comprises a fixed oral dosage form comprising a proton pump inhibitor in combination with acetyl salicylic acid. Furthermore the present invention refers to a method for the manufacture thereof and the use thereof in medicine. The present invention also relates to a specific combi...